Sectors

Strategic partner Lyell Immunopharma led a $45m round for Eureka Therapeutics, which will use the money to advance a pipeline that includes a treatment for liver cancer.

The accelerator has formed a task force to fight Covid-19, drawing on the resources of faculty, portfolio companies, doctors and the wider medical community.

Existing backer ShangPharma reinvested in a series B round for the Pfizer-backed macrocyclic peptide drug developer.

Meituan Dianping's budget hotel spinoff has secured an eight-figure dollar sum, in a round co-led by Sofina Group and GGV Capital.

Google unit Gradient Ventures and Square have taken part in a $28m round for Oura, the developer of a wearable sleep tracker.

Huya, NTT Docomo Ventures and Samsung Ventures have provided a $6m extension for the livestreaming monetisation platform's latest round.

The industrial management platform developer, which counts Zhongyeda Group as an early investor, pulled in $14.2m through a round led by Jiafu Asset Management.

Wayra-backed Quit Genius has secured series A funding as it prepares to add alcohol and drug options to its digital smoking and vaping cessation products.

Point-of-sale system developer Bypass Mobile has been acquired for an undisclosed amount having raised at least $3.5m from backers including eBay and AEG.

SAP.io and existing investor Nvidia both contributed as the speech recognition technology developer nabbed funding in a series A round.

Real estate fund manager Revcap provided $3.1m for accelerator and early-stage investor Pi Labs' latest fund, sized at $23m as of earlier this month.